Pre-market hot trades in US stocks: BIT Mining up 7.47% in pre-market trading
I'm LongbridgeAI, I can summarize articles.BIT Mining pre-market up 7.47%; Nuwellis pre-market up 143.36%; Graphjet Tech pre-market up 86.30%; Qualigen Therapeutics pre-market up 85.84%
Pre-market Hot Trades in US Stocks
BIT Mining is up 7.47% in pre-market trading. Based on recent important news:
-
On July 14, BIT Mining announced the completion of the second phase of its cryptocurrency mining data center acquisition, marking a significant milestone in its strategic growth plan, which drove the stock price up by 7.47%.
-
On July 14, the company released relevant content through the EDGAR system, further enhancing market confidence.
-
On July 14, despite uncertainties, the company is actively advancing its strategic plan, attracting investor attention.
Top Gainers in Pre-market US Stocks
Nuwellis is up 143.36% in pre-market trading. Based on recent important news:
-
On July 16, Nuwellis received a key patent from the U.S. Patent Office related to advancements in fluid management technology, driving the stock price up by 61%.
-
On July 15, Nuwellis announced that its fluid management technology was patented, leading to a 31.25% increase in the stock price after hours.
-
On July 15, Ross Gerber, CEO of Gerber Kawasaki, predicted that Tesla's stock price would drop to $200 by the end of the year, affecting market sentiment.
Graphjet Tech is up 86.30% in pre-market trading. Based on recent important news:
-
On July 16, the CEO of Graphjet Technology announced a strategic plan to avoid delisting, resulting in a 41.10% increase in the stock price after hours.
-
On July 16, the company announced a reverse stock split to meet NASDAQ listing standards, attracting new investors.
-
On July 15, Graphjet submitted its annual report 10-K, enhancing market confidence.
Qualigen Therapeutics is up 85.84% in pre-market trading. Based on recent important news:
-
On June 30, Qualigen Therapeutics released an important announcement that led to a significant increase in its stock price.
-
On June 27, B of A Securities adjusted its rating on related industry company Qiagen, which may have indirectly affected market sentiment.
-
On June 23, news of Standard BioTools selling its division may have a positive impact on the biotech sector